But medical device makers may finally get their legislative victory after the Republican-led Senate included a temporary end to the tax for another two years by a bipartisan vote of 81 to 18. The House of Representatives is also expected to include the medical device tax when it votes. The Joint Committee on Taxation has said repealing the medical device tax would cost the U.S. Treasury about $20 billion over a decade. AdvaMed represents hundreds of medical device makers, including Abbott Laboratories, Johnson & Johnson, Medtronic, Stryker and Zimmer. Device makers say the device tax hurt medical innovation, particularly at small firms, given that one-third of device makers have 20 or fewer employees.

Source: Forbes January 22, 2018 19:03 UTC